Clinical Trials Logo

Femoral Hernia clinical trials

View clinical trials related to Femoral Hernia.

Filter by:
  • None
  • Page 1

NCT ID: NCT05920200 Recruiting - Chronic Pain Clinical Trials

Factors Influencing the Results of Treatment in Patients With Hernias of Various Localizations

Start date: January 9, 2020
Phase:
Study type: Observational

The study attempts to quantify the relative risks for acute postoperative pain, complications rate, chronic postoperative pain (CPIP) and recurrence rate after different methods of repair of groin, umbilical and incisional hernia depending on surgical technique, mesh type and fixation suture material. For this purpose the investigators will analyze data from the Kalinigrad Hernia Registry (KHR).

NCT ID: NCT05306496 Recruiting - Inguinal Hernia Clinical Trials

Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap)

Start date: August 4, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and performance of the 4DMESH® used in (robot-assisted) laparoscopic inguinal and femoral hernia repair. The goal of the study will be achieved by assessing the prevalence of recurrences, pain, quality-of-life (QoL), return to daily activities and work and groin symptoms, and by reporting of peri- and postoperative complications in a prospectively maintained database.

NCT ID: NCT04009213 Completed - Inguinal Hernia Clinical Trials

A Clinical Study to Evaluate the Clinical Performance and Safety of LiquiBand FIX8® Versus AbsorbaTackā„¢ for Hernia Mesh Fixation and Peritoneal Closure in Groin Hernia Repair

Start date: August 22, 2019
Phase: N/A
Study type: Interventional

This is a multi-center, randomized controlled trial of 284 subjects (142 in each group). Patients will be blinded to the fixation method used. The objective of this study is to compare the efficacy and safety of the LiquiBand FIX8® device to the tack-based control device (AbsorbaTackā„¢) for laparoscopic groin hernia (inguinal or femoral) repair. The primary outcome measure is an improvement in pain score measured by VAS at 6 months. Secondary outcomes include the ability to affix hernia mesh, the ability to approximate the peritoneum, recurrence rate, and quality of life (Carolina Comfort Scale).

NCT ID: NCT01170780 Completed - Inguinal Hernia Clinical Trials

Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair

Start date: August 2010
Phase: Phase 3
Study type: Interventional

Does corticosteroid (dexamethasone) have an effect on the postoperative period after laparoscopic hernia repair, when it comes to pain, postoperative nausea and vomiting and convalescence. This randomized, double-blinded study compares dexamethasone versus placebo. The patients are recommended one day of convalescence. The medicine or placebo is given before operation. The patients fill out questionnaire before operation and three hours after operation and in the following three days. The patients also register when they return to normal activities and work.

NCT ID: NCT01105039 Completed - Inguinal Hernia Clinical Trials

Detailed Pain Pattern After Laparoscopic Inguinal Hernia Repair

Start date: November 2009
Phase: N/A
Study type: Observational

Pain after laparoscopic groin hernia repair consist of different pain components (overall pain, shoulder pain, incisional pain and visceral pain). Thus it is important to find out which of these pain components that is most severe, so intervention can be targeted.

NCT ID: NCT01000116 Completed - Inguinal Hernia Clinical Trials

Fibrin Glue Versus Tacked Fixation in Groin Hernia Repair (TAPP)

Start date: September 2009
Phase: N/A
Study type: Interventional

In this study the researchers want to compare fibrin glue versus tacked fixation in fixation of the mesh in laparoscopic groin hernia repair. The primary endpoints are early pain in the first 3 days postoperative days. Moreover, the researchers investigate general well-being, fatigue, seroma, haematoma, postoperative nausea and vomiting. Thirdly, they are investigating chronic pain and clinical recurrence.